Identification errors involving clinical laboratories: a College of American Pathologists Q-Probes study of patient

1, Paul N Valenstein, Stephen S Raab

  • 1Department of Pathology, St Joseph Mercy Hospital, Ann Arbor, Mich 48106-0998, USA. paul@valenstein.org

Abstract

Insights

Laboratory specimen identification errors are frequent but mostly caught before release. While most errors cause inconvenience, over 160,000 adverse events may occur annually in US labs due to misidentification.

Area of Science:

  • Clinical Laboratory Science
  • Patient Safety
  • Medical Diagnostics

Background:

  • Misidentified laboratory specimens pose a risk of patient harm.
  • The actual frequency of specimen misidentification in clinical practice is not well-documented.

Purpose of the Study:

  • To quantify the frequency of laboratory specimen identification errors before and after result verification.
  • To determine the incidence of adverse patient events linked to specimen misidentification.
  • To identify factors influencing error rates and detection efficacy.

Main Methods:

  • A 5-week data collection period involving 120 clinical laboratories.
  • Information gathered on identification errors and associated adverse events.

Main Results:

  • 85% of identification errors were detected prior to result release.
  • The rate of patient identification errors in released results was 55 per million tests.
  • Approximately 1 in 18 identification errors led to an adverse event, potentially exceeding 160,000 annually in US labs.

Conclusions:

  • Identification errors in laboratory medicine are common, yet most are intercepted before results are issued.
  • A small proportion of errors result in adverse patient events, though most cause minor inconvenience.
  • Improved internal error detection correlates with a lower rate of misidentified specimens being released.